ICM
Invenomic Capital Management’s Stride LRN Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-67,739
| Closed | -$4.27M | – | 172 |
|
2024
Q1 | $4.27M | Buy |
67,739
+9,038
| +15% | +$570K | 0.23% | 103 |
|
2023
Q4 | $3.49M | Sell |
58,701
-296,489
| -83% | -$17.6M | 0.16% | 116 |
|
2023
Q3 | $16M | Buy |
355,190
+171,591
| +93% | +$7.73M | 0.67% | 48 |
|
2023
Q2 | $6.84M | Sell |
183,599
-18,333
| -9% | -$683K | 0.35% | 73 |
|
2023
Q1 | $7.93M | Sell |
201,932
-307,471
| -60% | -$12.1M | 0.45% | 64 |
|
2022
Q4 | $15.9M | Buy |
509,403
+394,200
| +342% | +$12.3M | 1.08% | 25 |
|
2022
Q3 | $4.84M | Sell |
115,203
-202,261
| -64% | -$8.5M | 0.42% | 78 |
|
2022
Q2 | $12.9M | Buy |
317,464
+50,857
| +19% | +$2.07M | 0.92% | 29 |
|
2022
Q1 | $9.69M | Sell |
266,607
-110,618
| -29% | -$4.02M | 1.03% | 22 |
|
2021
Q4 | $12.6M | Buy |
377,225
+128,022
| +51% | +$4.27M | 2.69% | 1 |
|
2021
Q3 | $8.96M | Sell |
249,203
-29,868
| -11% | -$1.07M | 2.91% | 2 |
|
2021
Q2 | $8.97M | Buy |
279,071
+93,000
| +50% | +$2.99M | 2.15% | 1 |
|
2021
Q1 | $5.6M | Sell |
186,071
-32,516
| -15% | -$979K | 1.25% | 6 |
|
2020
Q4 | $4.64M | Buy |
218,587
+114,787
| +111% | +$2.44M | 1.18% | 3 |
|
2020
Q3 | $2.73M | Sell |
103,800
-88,117
| -46% | -$2.32M | 1.51% | 9 |
|
2020
Q2 | $5.23M | Sell |
191,917
-28,463
| -13% | -$775K | 3.87% | 1 |
|
2020
Q1 | $4.16M | Buy |
+220,380
| New | +$4.16M | 3.4% | 1 |
|